ODN 2216-Type A (human, Negative Control) (VAdv-Ly0075)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VAdv-Ly0075 |
|
ODN 2216-Type A, human TLR9 agonist, oligodeoxynucleotide vaccine adjuvant.
Datasheet
Specifications
Type
CpG
Molecular Weight
6644
Specificity
TLR9 agonist
Product Form
Powder
Percentage
≥ 95%
Endotoxin
Lower than 2 EU/mg.
Storage
Store at -20°C.
Shelf Life
1 year.
Adjuvant Information
Introduction
ODN 2216 is a type A human TLR9 agonist. CpG ODNs 2216 can induce strong Th1-like immune activation, with the secretion of type-I cytokine and activation of strong CD8+ T-cell responses. PBMNCs activated by CpG ODNs can more strongly kill k562 cells in vitro.
Sequence
5'-ggGGGAGCATGCTGgggggc-3' (20 mer)
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
